Products
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
BioGene Pharmaceutical Ltd.
Country
Ownership
Private
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Safety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the Endometriosis
Phase 1
Withdrawn
Conditions
Endometriosis Ovary
Endometriosis
Endometriosis Externa
Endometriosis, Rectum
Interventions
Biological: Linifanib
Drug: BIBW2992
Drug: Axitinib
Subscribe
First Posted Date
2018-03-29
Last Posted Date
2021-10-29
Lead Sponsor
BioGene Pharmaceutical Ltd.
Registration Number
NCT03481842
Locations
🇨ðŸ‡
BioGene Pharmaceutical Ltd., Basel, Вâlе, Switzerland
Subscribe
Prev
1
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy